Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes and obesity. It acts as an analog of the human glucagon-like peptide-1 hormone, which is involved in regulating blood sugar levels and food intake. Semaglutide acts by stimulating the release of insulin from pancreatic beta cells and suppressing glucagon secretion from pancreatic alpha...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian